• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

Compound CAS No. 1158310-32-7: (4-Fluoro-1H-indol-3-yl)methanol

(4-Fluoro-1H-indol-3-yl)methanol, also known by its CAS number 1158310-32-7, is a fascinating compound that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of indole derivatives, which are known for their diverse biological activities and structural versatility. The presence of a fluorine atom at the 4-position of the indole ring introduces unique electronic and steric properties, making this compound particularly interesting for various applications.

The molecular structure of (4-fluoroindolyl)methanol consists of an indole ring system with a fluorine substituent at position 4 and a hydroxymethyl group (-CH?OH) attached at position 3. This arrangement not only enhances the compound's stability but also provides opportunities for further functionalization. Recent studies have highlighted the potential of this compound in drug discovery, particularly in the development of anticancer agents and neuroprotective drugs.

One of the most notable aspects of CAS No. 1158310-32-7 is its ability to act as a precursor in the synthesis of more complex molecules. For instance, researchers have utilized this compound as a starting material for constructing bioactive compounds with improved pharmacokinetic profiles. The hydroxymethyl group serves as a reactive site, enabling various chemical transformations such as oxidation, reduction, and coupling reactions.

Recent advancements in synthetic methodologies have made it possible to produce (4-fluoroindolyl)methanol in high yields and with excellent purity. These methods often involve multi-step synthesis strategies that incorporate fluorination techniques and stereochemical control. The use of microwave-assisted synthesis has also been reported, significantly reducing reaction times while maintaining product quality.

In terms of biological activity, CAS No. 1158310-32-7 has shown promising results in vitro against several cancer cell lines. Studies indicate that the compound exhibits selective cytotoxicity, potentially due to its ability to modulate key cellular pathways involved in apoptosis and cell proliferation. Additionally, preliminary animal studies suggest that this compound may have neuroprotective effects, making it a candidate for treating neurodegenerative diseases such as Alzheimer's disease.

The pharmacokinetic properties of (4-fluoroindolyl)methanol have also been investigated. Research findings reveal that the compound demonstrates moderate absorption and distribution characteristics, with a favorable half-life profile. These attributes make it a viable candidate for further preclinical testing and eventual clinical trials.

In conclusion, CAS No. 1158310-32-7, or (4-fluoroindolyl)methanol, represents a valuable addition to the arsenal of bioactive compounds available for drug discovery. Its unique structure, coupled with its promising biological activity, positions it as a potential lead molecule for developing innovative therapeutic agents. As research continues to uncover its full potential, this compound is likely to play an increasingly important role in advancing medical science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)